| Oct 18 |
FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
|
| Oct 18 |
High Growth Tech Stocks to Watch in October 2024
|
| Oct 17 |
Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
|
| Oct 17 |
Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
|
| Oct 17 |
Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
|
| Oct 16 |
Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
|
| Oct 15 |
RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
|
| Oct 11 |
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
|
| Oct 11 |
3 US Stocks Estimated To Be Trading At Up To 46.6% Discount
|
| Oct 9 |
Biotech Eyes Early Entry As Several Factors Could Unleash Shares
|
